- Home
- ADT vs RGEN Comparison
ADT vs RGEN Comparison
Compare ADT & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADT
- RGEN
- Stock Information
- Founded
- ADT 1874
- RGEN 1981
- Country
- ADT United States
- RGEN United States
- Employees
- ADT N/A
- RGEN N/A
- Industry
- ADT Diversified Commercial Services
- RGEN Medical/Dental Instruments
- Sector
- ADT Consumer Discretionary
- RGEN Health Care
- Exchange
- ADT Nasdaq
- RGEN Nasdaq
- Market Cap
- ADT 7.0B
- RGEN 6.6B
- IPO Year
- ADT 2018
- RGEN N/A
- Fundamental
- Price
- ADT $8.76
- RGEN $118.88
- Analyst Decision
- ADT Buy
- RGEN Buy
- Analyst Count
- ADT 5
- RGEN 9
- Target Price
- ADT $9.34
- RGEN $167.38
- AVG Volume (30 Days)
- ADT 10.3M
- RGEN 721.7K
- Earning Date
- ADT 10-23-2025
- RGEN 07-29-2025
- Dividend Yield
- ADT 2.51%
- RGEN N/A
- EPS Growth
- ADT N/A
- RGEN N/A
- EPS
- ADT 0.68
- RGEN N/A
- Revenue
- ADT $5,058,741,000.00
- RGEN $673,956,000.00
- Revenue This Year
- ADT $6.18
- RGEN $14.14
- Revenue Next Year
- ADT $4.23
- RGEN $14.32
- P/E Ratio
- ADT $12.89
- RGEN N/A
- Revenue Growth
- ADT 6.58
- RGEN 8.73
- 52 Week Low
- ADT $6.68
- RGEN $102.97
- 52 Week High
- ADT $8.86
- RGEN $182.52
- Technical
- Relative Strength Index (RSI)
- ADT 56.81
- RGEN 46.92
- Support Level
- ADT $8.60
- RGEN $119.29
- Resistance Level
- ADT $8.86
- RGEN $127.21
- Average True Range (ATR)
- ADT 0.16
- RGEN 4.14
- MACD
- ADT 0.01
- RGEN 0.08
- Stochastic Oscillator
- ADT 80.77
- RGEN 45.88
About ADT ADT Inc.
ADT Inc is a provider of security, interactive, and smart home solutions serving consumer and small business customers in the United States (U.S.). The Company conducts business under the ADT brand name. The company segments include Consumer and Small Business (CSB).
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.